Drug: Bevacizumab Injury: Febrile neutropenia Quarter: 2016Q3
Total Records: 36 Number of Pages: 2
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 126128551 | Bevacizumab | Febrile neutropenia | ROCHE | 0.00 | 0 | 20160802 | US | |
| 126251631 | BEVACIZUMAB | Febrile neutropenia | JANSSEN | 0.00 | F | 0 | 20160805 | US |
| 126267892 | BEVACIZUMAB | Febrile neutropenia | AMGEN | 0.00 | F | 0 | 20160812 | US |
| 126513522 | Bevacizumab | Febrile neutropenia | ROCHE | 64.00 YR | F | 0 | 20160822 | JP |
| 127202191 | Bevacizumab | Febrile neutropenia | ROCHE | 0.00 | 0 | 20160907 | US | |
| 127237541 | Bevacizumab | Febrile neutropenia | ROCHE | 8.00 YR | M | 30 KG | 20160908 | US |
| 127362261 | Bevacizumab | Febrile neutropenia | ROCHE | 77.00 YR | M | 73 KG | 20160913 | US |
| 127409651 | Bevacizumab | Febrile neutropenia | ROCHE | 63.00 YR | M | 0 | 20160914 | VN |
| 127413191 | Bevacizumab | Febrile neutropenia | ROCHE | 72.00 YR | M | 65 KG | 20160914 | US |
| 127415161 | Bevacizumab | Febrile neutropenia | ROCHE | 55.00 YR | M | 76 KG | 20160914 | US |
| 127451811 | Bevacizumab | Febrile neutropenia | ROCHE | 52.00 YR | M | 84 KG | 20160915 | US |
| 127583731 | BEVACIZUMAB | Febrile neutropenia | ASTELLAS | 63.00 YR | F | 0 | 20160919 | GB |
| 127699001 | Bevacizumab | Febrile neutropenia | ROCHE | 12.00 YR | F | 28 KG | 20160922 | CA |
| 127833001 | Bevacizumab | Febrile neutropenia | ROCHE | 0.00 | 0 | 20160927 | JP | |
| 127873221 | Bevacizumab | Febrile neutropenia | ROCHE | 67.00 YR | F | 0 | 20160927 | US |
| 127907991 | Bevacizumab | Febrile neutropenia | ROCHE | 65.00 YR | F | 100 KG | 20160929 | US |
Total Records: 36 Number of Pages: 2